Nijmegen

• The effect of Janus Kinase inhibitors on the heart in Rheumatoid Arthritis Pending
  2025-520710-58-00 6 Diagnosis of RA according to the ACR/EULAR 2010 criteria without a his
• A maintenance study to investigate the efficacy and safety of duvakitug in participants with moderately to severely active Crohn’s disease Pending
  2025-521037-86-00 5 Immune system diseases
• A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease Pending
  2025-521113-13-00 10 Early Parkinson’s Disease
• Research into the effect of Obinutuzumab on the level of PLA2R antibodies in patients with membranous nephropathy. Pending
  2025-521139-35-01 4 Primary membranous nephropathy
• Clinical trial to assess the safety and tolerability of TP-122A for the treatment of ventilator-associated pneumonia. Pending
  2025-521533-85-00 7 Ventilator-Associated Pneumonia
• The NIMBUS study: A study on inhalation therapy with liposomal amphotericin B and its distribution in the lungs in chronic pulmonary fungal … Pending
  2025-521770-34-00 3 Chronic pulmonary aspergillosis
• A study in people with advanced cancer (solid tumours) to test different doses of BI 3810944 and to find out whether it helps Pending
  2025-522045-21-00 1 Solid tumours
• REVITALISE Study Pending
  2025-522060-32-00 4 STEMI (ST elevated Myocardial Infarction)
• Impact Of Upadacitinib On The Frequency Of Acute Recurrent Anterior Uveitis In Patients With Axial Spondyloarthritis Pending
  2025-522118-21-00 6 Acute Anterior Uveitis
• An Open-Label, Single-Arm, 3-Year Extension Study to Evaluate Safety and Tolerability of Tinlarebant in Subjects with Stargardt Disease Pending
  2025-522460-33-00 5 Stargardt Disease
• T cell imaging in kidney transplantation (TIK) Pending
  2025-522490-11-00 3 Renal allograft rejection
• Phase 3 Study of INCB123667 Versus Investigator's Choice of Chemotherapy in Platinum Resistant Ovarian Cancer With Cyclin E1 Overexpression Pending
  2025-522748-42-00 5 Ovarian cancer
• A Study of Vepugratinib (LY3866288) in Participants with Cancer in the Urinary Tract ( FORAGER-2 ) Pending
  2025-522855-25-00 5 Urinary Bladder Neoplasms
• SHIELD – Swift Hydrocortisone Intervention after trauma exposure Pending
  2025-523350-13-02 4 Posttraumatic Stress Disorder (PTSD)
• Safety and Efficacy of VX-828/Deutivacaftor Combination Therapy With and Without Tezacaftor in Subjects With Cystic Fibrosis Pending
  2025-523400-72-00 4 Cystic fibrosis
• A Phase 1/2, Open-label Study of VS-7375, a KRAS G12D (ON/OFF) Inhibitor, as Monotherapy and in Combination, in Patients with Advanced KRAS … Pending
  2025-523432-39-01 9 Advanced KRAS G12D-Mutant Solid Tumors
• Efficacy and safety of vamifeport in adult subjects with HFE-related hereditary hemochromatosis Pending
  2025-523793-16-00 4 Homeostatic iron regulator gene-related hereditary hemochromatosis
• Adjuvant Pembrolizumab in patients with early-stage triple negative breast cancer with residual disease after treatment with chemotherapy an … Pending
  2025-524229-41-00 5 Triple negative breast cancer
• Healing Diabetic Foot Ulcers with Semaglutide Pending
  2025-524738-24-00 6 Diabetic foot ulcer
• PET imaging For eaRly predictiOn of respoNse to neoadjuvanT tReatment in lUNg caNcER Pending
  2025-524791-30-00 9 Non small cell lung cancer
• An International, Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Trial on the Effects of EA-230 on the Length of Hospit … Pending
  2025-525053-39-00 5 Coronary artery disease
• A Phase 2, Open-Label Long-Term Extension Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon Skipping to Evaluate the S … Pending
  2025-525124-10-00 4 Duchenne Muscular Dystrophy
• A clinical study investigating modafinil for the treatment of severe fatigue in patients with inflammatory bowel disease (MODIFI-IBD trial) Pending
  2026-525163-41-00 10 Inflammatory bowel disease
• PLUTO Pending
  2026-525211-14-00 4 HIV-1

Showing 25–48 of 570 trials